Maple Capital Management, Inc. Eli Lilly & CO Transaction History

Maple Capital Management, Inc.

$1.23 Billion
Q2 2024

A detailed history of Maple Capital Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Maple Capital Management, Inc. holds 46,593 shares of LLY stock, worth $41.3 Million. This represents 3.42% of its overall portfolio holdings.

Number of Shares

46,593

Previous 46,472 0.26%

Holding current value

$41.3 Million

Previous $36.2 Million 16.68%

% of portfolio

3.42%

Previous 3.29%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$724.87 - $909.04 $87,709 - $109,993	121 Added 0.26%	46,593 $42.2 Million
Q1 2024 May 09, 2024	SELL	$592.2 - $792.28 $562,590 - $752,666	-950 Reduced 2.0%	46,472 $36.2 Million
Q4 2023 Feb 07, 2024	SELL	$525.19 - $619.13 $1.53 Million - $1.8 Million	-2,911 Reduced 5.78%	47,422 $27.6 Million
Q3 2023 Oct 10, 2023	SELL	$434.7 - $599.3 $1.58 Million - $2.17 Million	-3,628 Reduced 6.72%	50,333 $27 Million
Q2 2023 Jul 14, 2023	SELL	$350.74 - $468.98 $101,714 - $136,004	-290 Reduced 0.53%	53,961 $25.3 Million
Q1 2023 May 02, 2023	SELL	$310.63 - $364.82 $261,239 - $306,813	-841 Reduced 1.53%	54,251 $18.6 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $530,235 - $617,830	-1,649 Reduced 2.91%	55,092 $20.2 Million
Q3 2022 Nov 15, 2022	SELL	$296.48 - $337.87 $5.95 Million - $6.78 Million	-20,059 Reduced 26.12%	56,741 $20.2 Million
Q2 2022 Aug 02, 2022	BUY	$278.73 - $327.27 $309,947 - $363,924	1,112 Added 1.47%	76,800 $24.9 Million
Q1 2022 May 17, 2022	SELL	$234.69 - $291.66 $38,489 - $47,832	-164 Reduced 0.22%	75,688 $21.7 Million
Q4 2021 Feb 15, 2022	SELL	$224.85 - $279.04 $304,446 - $377,820	-1,354 Reduced 1.75%	75,852 $21 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $337,718 - $415,610	-1,524 Reduced 1.94%	77,206 $17.8 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $231,104 - $298,931	-1,280 Reduced 1.6%	78,730 $20.8 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $23,990 - $31,057	-146 Reduced 0.18%	80,010 $14.9 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $56,880 - $75,266	-436 Reduced 0.54%	80,156 $13.5 Million
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $112,296 - $129,891	768 Added 0.96%	80,592 $11.5 Million
Q2 2020 Aug 12, 2020	SELL	$136.42 - $164.18 $155,245 - $186,836	-1,138 Reduced 1.41%	79,824 $13.1 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $243,695 - $301,625	-2,047 Reduced 2.47%	80,962 $11.2 Million
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $72,919 - $90,317	682 Added 0.83%	83,009 $10.9 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $476,603 - $518,422	-4,463 Reduced 5.14%	82,327 $9.21 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $500,438 - $584,138	-4,517 Reduced 4.95%	86,790 $9.62 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $945,912 - $1.11 Million	-8,498 Reduced 8.51%	91,307 $11.8 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $49,773 - $55,760	470 Added 0.47%	99,805 $11.5 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $40,611 - $50,757	-473 Reduced 0.47%	99,335 $0
Q2 2018 Aug 08, 2018	BUY	$75.7 - $86.88 $28,009 - $32,145	370 Added 0.37%	99,808 $0
Q1 2018 May 11, 2018	BUY	$74.21 - $87.6 $135,210 - $159,607	1,822 Added 1.87%	99,438 $0
Q4 2017 Feb 15, 2018	BUY	$81.94 - $87.89 $118,813 - $127,440	1,450 Added 1.51%	97,616 $8.25 Million
Q3 2017 Nov 03, 2017	BUY	$77.07 - $85.54 $7.41 Million - $8.23 Million	96,166	96,166 $8.23 Million

Others Institutions Holding LLY

# of Institutions

3,870

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $841B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Maple Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Maple Capital Management, Inc. with notifications on news.

Account

Maple Capital Management, Inc. Eli Lilly & CO Transaction History